1887

Abstract

Among the 162 isolates collected in the Taiwan Surveillance of Antimicrobial Resistance of Yeasts in 1999, 23 (14.2 %) had fluconazole MICs ≥64 mg l, and thus fulfilled the definition of resistance. Random amplified polymorphic DNA assay showed that all 23 fluconazole-resistance isolates collected from different hospitals around Taiwan were closely related. Two distinct pulsotypes associated with fluconazole susceptibility were identified when these 23 resistant isolates, along with 13 susceptible ones, were analysed by PFGE.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46664-0
2007-05-01
2024-12-08
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/5/650.html?itemId=/content/journal/jmm/10.1099/jmm.0.46664-0&mimeType=html&fmt=ahah

References

  1. Arthington-Skaggs B. A., Lee-Yang W., Ciblak M. A., Frade J. P., Brandt M. E., Hajjeh R. A., Harrison L. H., Sofair A. N., Warnock D. W. 2002; Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 46:2477–2481 [CrossRef]
    [Google Scholar]
  2. Chen Y. C., Chang S. C., Tai H. M., Hsueh P. R., Luh K. T. 2001; Molecular epidemiology of Candida colonizing critically ill patients in intensive care units. J Formos Med Assoc 100:791–797
    [Google Scholar]
  3. Chen K. W., Lo H. J., Lin Y. H., Li S. Y. 2005; Comparison of four molecular typing methods to assess genetic relatedness of Candida albicans clinical isolates in Taiwan. J Med Microbiol 54:249–258 [CrossRef]
    [Google Scholar]
  4. Cheng M. F., Yu K. W., Tang R. B., Fan Y. H., Yang Y. L., Hsieh K. S., Ho M., Lo H. J. 2004; Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 48:33–37 [CrossRef]
    [Google Scholar]
  5. Clinical and Laboratory Standards Institute 1997 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts , approved standard M27-A Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  6. Ergon M. C., Gulay Z. 2005; Molecular epidemiology of Candida species isolated from urine at an intensive care unit. Mycoses 48:126–131 [CrossRef]
    [Google Scholar]
  7. Lee M. K., Williams L. E., Warnock D. W., Arthington-Skaggs B. A. 2004; Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53:217–224 [CrossRef]
    [Google Scholar]
  8. Li S. Y., Yang Y. L., Chen K. W., Cheng H. H., Chiou C. S., Wang T. H., Lauderdale T. L., Hung C. C., Lo H. J. 2006; Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Epidemiol Infect 134:265–269
    [Google Scholar]
  9. Lo H.-J., Ho Y.-A., Ho M. 2001; Factors accounting for misidentification of Candida species. J Microbiol Immunol Infect 34:171–177
    [Google Scholar]
  10. Pfaller M. A., Jones R. N., Doern G. V., Sader H. S., Messer S. A., Houston A., Coffman S., Hollis R. J. 2000; Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997–1998. Antimicrob Agents Chemother 44:747–751 [CrossRef]
    [Google Scholar]
  11. Roilides E., Farmaki E., Evdoridou J., Francesconi A., Kasai M., Filioti J., Tsivitanidou M., Sofianou D., Kremenopoulos G., Walsh T. J. 2003; Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41:735–741 [CrossRef]
    [Google Scholar]
  12. Sanglard D., Odds F. C. 2002; Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73–85 [CrossRef]
    [Google Scholar]
  13. Tavanti A., Davidson A. D., Johnson E. M., Maiden M. C., Shaw D. J., Gow N. A., Odds F. C. 2005; Multilocus sequence typing for differentiation of strains of Candida tropicalis . J Clin Microbiol 43:5593–5600 [CrossRef]
    [Google Scholar]
  14. Walsh T. J., Groll A., Hiemenz J., Fleming R., Roilides E., Anaissie E. 2004; Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 10, (Suppl. 1):48–66 [CrossRef]
    [Google Scholar]
  15. Yang Y. L., Cheng H. H., Ho Y. A., Hsiao C. F., Lo H. J. 2003; Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect 36:187–191
    [Google Scholar]
  16. Yang Y. L., Ho Y. A., Cheng H. H., Ho M., Lo H. J. 2004; Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis . Infect Control Hosp Epidemiol 25:60–64 [CrossRef]
    [Google Scholar]
  17. Yang Y. L., Ho Y. A., Cheng H. H., Lo H. J. 2005; Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan. Epidemiol Infect 133:325–330 [CrossRef]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.46664-0
Loading
/content/journal/jmm/10.1099/jmm.0.46664-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error